Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,050.00    -69.00 (-6.17%)
Bid:
1,050.50
Ask:
1,051.50
Spread: 1.00 (0.095%)
Market Cap: £3.37b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Update

9 Jan 2018 07:00

RNS Number : 2733B
Persimmon PLC
09 January 2018
 

TRADING UPDATE - 9 JANUARY 2018

 

 

Persimmon plc announces the following update ahead of its Final Results for the year ended 31 December 2017, which will be released on 27 February 2018.

 

Revenues for 2017 of £3.42bn were 9% higher than the prior year (2016: £3.14bn) with legal completion volumes strongly ahead by 872 new homes (6% increase) to 16,043 (2016: 15,171). The Group's average selling price increased by 3% to c. £213,300 (2016: £206,765).

 

Since the launch of our Group strategy in 2012 we have made a significant contribution to increasing UK housing supply by opening 1,189 new selling outlets and delivering 80,726 new homes to the market during which time we have increased our annual production by over 70%.

 

We continued to experience healthy customer demand for new homes through the autumn sales season and the value of our forward sales at 31 December 2017 of c. £1,355m was 10% ahead of the prior year (2016: £1,234m). Second half legal completion volumes of 8,249 were 455 stronger than for the first half of the year (H1: 7,794), an increase of 6%.

 

We anticipate our pre-tax profits for the year will be modestly ahead of market consensus.

The Group continues to pursue disciplined high-quality growth in its regional markets in support of the Government's desire to increase housing supply across the UK. We opened a new operating business in Mansfield, north of Nottingham, on 2 January 2017 which has made good progress, legally completing 373 new homes in 2017. In addition, on 2 January 2018, we launched a new business based near Ipswich in Suffolk to improve our operational capability and supplement our existing operations in the east of England. Over the last three years we have opened 6 new offices, raising the number of regional house building businesses within the Group from 24 to 30 demonstrating our commitment to increasing supply where there is good demand and we will continue to explore opportunities for further growth.

 

The Group successfully opened 197 new sales outlets during the year and is building on all sites which have an implementable planning consent. The Group now has 375 active sales outlets which we anticipate will provide good support to sales moving into the 2018 spring selling season.

 

We have made excellent progress in expanding our manufacturing capabilities to support our desire to achieve sustainable growth. Our new brick manufacturing plant in Harworth, near Doncaster, is now complete and deliveries of bricks to site have commenced, underpinning our ability to increase house building volumes. The Group's Space4 insulated frame build-system is also an important contributor to our overall construction capacity and we anticipate further investment in expanding this capability over the coming years.

 

We continue to invest for future growth and have acquired c. 17,300 plots of new land at excellent margins in over 80 locations throughout the UK during the year. We remain mindful of market risks including those associated with the uncertainty arising from the UK leaving the EU. However, we are keen to deliver further improvement in our housing output and remain ready to invest wherever the local planning environment is supportive.

 

The Group continues to perform strongly in generating free cash and held cash balances of c. £1,300m at 31 December 2017 (2016: £913m).

 

We will provide further details and give an update on our assessment of the housing market over the early weeks of 2018 when we announce our results for the year ended 31 December 2017 on Tuesday 27 February 2018.

 

 

 

Please Note

There will be a call for analysts at 09.00 GMT today. Please use the dial-in details below:

 

Telephone number:

+44 (0)33 3300 0804

Access pin:

81885462#

Passcode:

Persimmon

 

An audiocast of the call will be available on www.corporate.persimmonhomes.com 

 

 

For further information please contact:

 

Jeff Fairburn, Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Jos Bieneman

Persimmon plc

Citigate Dewe Rogerson

Tel: +44 (0) 1904 642199

Tel: +44 (0) 20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGGMVRVGRZM
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.